Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
33.82+1.17 (+3.58%)
At close: 04:00PM EDT
33.82 0.00 (0.00%)
After hours: 07:59PM EDT
Advertisement
Full screen
Loading interactive chart...
  • Motley Fool

    3 Cathie Wood Stocks for the Future

    Unlike a lot of tech investors, Cathie Wood is super bullish on biotechnology. Here are three of her picks that these Motley Fool contributors love.

  • GlobeNewswire

    Fate Therapeutics Announces Preclinical Publication Highlighting Derivation of CD8αβ T Cells from TCR-CAR+ Induced Pluripotent Stem Cells

    TCR-CAR+ iPSC-derived CD8αβ T Cells Induced Complete and Durable Responses In Vivo in Systemic Leukemia Model Cell-surface Markers, Gene Transcription Profile, and In Vivo Anti-tumor Activity of TCR-CAR+ iPSC-derived CD8αβ T Cells Compared Favorably with Healthy-donor Peripheral Blood CAR T Cells Phase 1 Study Ongoing of First-ever iPSC-derived T-cell Product Candidate FT819 for Off-the-shelf Treatment of Patients with Relapsed / Refractory B-cell Malignancies SAN DIEGO, Aug. 09, 2022 (GLOBE NEW

  • InvestorPlace

    7 Small-Cap Stocks to Buy Before the Bull Market Returns

    Small-cap stocks with lower market capitalizations ranging from $300 million to $2 billion have taken quite a hit since January. These stocks typically belong to smaller companies with massive long-term growth potential. However, they are sensitive to rising inflation and interest rate hikes due to tighter profits and weak balance sheets. Therefore these stocks have taken a bigger hit compared to the broader market. The Russell 2000’s performance is a testament to that, so it’s best to pick up s

Advertisement
Advertisement